| Page 675 | Kisaco Research
Gregory Bryant Gov Juan F. Luis Hospital & Medical Center
Download the Brochure below

• How are we ensuring under-served patient populations voices are considered in trial format?

• Optimizing both population data and clinical data analytics to develop accessible and equitable clinical trials.

Author:

Brittany Gerald

Clinical Trial Health Equity Leader & Founder
Pathway to Pharma

Brittany earned her Bachelor of Science degree from Wake Forest University and brings over 17 years of experience in clinical research across the Sponsor, CRO, and Site levels. Her expertise spans a wide range of therapeutic areas, including cardiology, endocrinology, immunology, neurology, oncology, women’s health, and vaccines. Throughout her career, Brittany has contributed to more than 45 clinical trials, working with various pharmaceutical companies and Contract Research Organizations.

A passionate advocate for health equity, Brittany is dedicated to promoting health equity and representation in clinical research. She actively participates in discussions and panels focused on equity in clinical trials, sharing her knowledge and strategies for fostering inclusivity. Her leadership and commitment to ensuring representation in clinical research plays a pivotal role in advancing health outcomes for all communities, building trust, and making medical innovations accessible to everyone.

Brittany Gerald

Clinical Trial Health Equity Leader & Founder
Pathway to Pharma

Brittany earned her Bachelor of Science degree from Wake Forest University and brings over 17 years of experience in clinical research across the Sponsor, CRO, and Site levels. Her expertise spans a wide range of therapeutic areas, including cardiology, endocrinology, immunology, neurology, oncology, women’s health, and vaccines. Throughout her career, Brittany has contributed to more than 45 clinical trials, working with various pharmaceutical companies and Contract Research Organizations.

A passionate advocate for health equity, Brittany is dedicated to promoting health equity and representation in clinical research. She actively participates in discussions and panels focused on equity in clinical trials, sharing her knowledge and strategies for fostering inclusivity. Her leadership and commitment to ensuring representation in clinical research plays a pivotal role in advancing health outcomes for all communities, building trust, and making medical innovations accessible to everyone.

Author:

Benjamin Young

Senior Global Medical Director
ViiV Healthcare

Benjamin Young

Senior Global Medical Director
ViiV Healthcare

Author:

Sandra Amaro

Head of Clinical Trial Diversity
Pfizer

Sandra Amaro

Head of Clinical Trial Diversity
Pfizer

• Improving global data collection and analytics to provide direction of health equity strategies.

• Discussing pharmaceutical solutions for health equity through clinical trial diversity in the United States.

• Reviewing the global health equity landscape through the lens of regulation and collaboration efforts.

Author:

Denise Bronner

CEO
Empactful Ventures

Denise Bronner

CEO
Empactful Ventures

Author:

Kemi Willaims

Senior Director, Patient Science
AstraZeneca

Kemi Willaims

Senior Director, Patient Science
AstraZeneca

Author:

Keith Dawson

Principal Global Health Equity & Population Science
Genentech

Keith Dawson

Principal Global Health Equity & Population Science
Genentech